[Pemphigus herpetiformis].
Wosnitza
M
M
Klinik für Allergologie und Dermatologie, Universitätsklinikum Aachen, Pauwelsstrabe 30, 52074, Aachen, Deutschland. mwosnitza@ukaachen.de
Blazek
C
C
Megahed
M
M
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001323:Autoantibodies / Q000097:blood; D001706:Biopsy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007868:Leg Dermatoses / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D012867:Skin / Q000276:immunology / Q000473:pathology
D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D011239:Prednisolone; D009173:Mycophenolic Acid